John Yianni
Founder at Thermocore Medical Ltd.
Profile
John Yianni is the founder of Cryotherapeutics SA, where he holds the title of Chief Executive Officer starting in 2011.
He is also the founder of Thermocore Medical Ltd.
Dr. Yianni's current job is as a Partner at Earlybird Venture Capital GmbH & Co. KG, starting in 2016.
Dr. Yianni's former jobs include being a Director at Arthro Kinetics Ltd.
in 2011, a Director at Reverse Medical Corp., and Vice President-Technology & Business Development at Biocompatibles International Ltd.
John Yianni active positions
Companies | Position | Start |
---|---|---|
Thermocore Medical Ltd. | Founder | 2011-05-18 |
Cryotherapeutics SA
Cryotherapeutics SA Medical SpecialtiesHealth Technology Cryotherapeutics SA develops and markets a cryotherapy system, with focus on highlighting the safety and efficacy of cryoneergy in the cardiovascular system. The firm specializes in the design of a proprietary system to be used in the treatment of coronary artery diseases that cause heart attacks. Its focus areas encompass technology research, system development, and early-stage product commercialization. The company was founded by Randell L. Werneth, John Yianni and Maurice Buchbinder on September 8, 2009 and is headquartered in Cologne, Germany. | Chief Executive Officer | 2011-05-18 |
Earlybird Venture Capital GmbH & Co. KG
Earlybird Venture Capital GmbH & Co. KG Investment ManagersFinance Earlybird Venture Capital GmbH & Co. KG (Earlybird VC) is an independent venture capital firm founded by Hendrik Brandis, Roland Manger, Rolf Mathies, and Christian Nagel in 1997. It is a wholly-owned subsidiary of Earlybird VC Management GmbH & Co. KG. The firm is headquartered in Munich, Germany, with another German office in Berlin, and international office in Istanbul, Turkey. | Private Equity Investor | 2016-07-31 |
Former positions of John Yianni
Companies | Position | End |
---|---|---|
Arthro Kinetics Ltd.
Arthro Kinetics Ltd. Medical SpecialtiesHealth Technology Arthro Kinetics develops manufactures and markets advanced biological implants for joint regeneration and surgical instrument and access systems for endoscopic spine surgery. The Company aims to develop a portfolio of biological implants for insertion by endoscopic spine surgery techniques, thereby setting new standards of surgical care. The Company has developed and is marketing CaReS, its first biological cartilage repair product, and K.I.S.S., its comprehensive spinal surgical instruments system for endoscopic spinal access and surgical intervention. | Director/Board Member | 2011-07-19 |
Reverse Medical Corp.
Reverse Medical Corp. Electronic Equipment/InstrumentsElectronic Technology Reverse Medical Corp. develops medical devices. The company was founded by Jeffrey Valko and Michael R. Henson in 2007 and is headquartered in Irvine, CA. | Director/Board Member | - |
Biocompatibles International Ltd.
Biocompatibles International Ltd. Miscellaneous Commercial ServicesCommercial Services Biocompatibles International Ltd. is a leading medical technology company in the field of drug device combination products with an Oncology products division and a Licensing division. In oncology, it has Bead products and BrachySciences and in Licensing, it has two components, CellMed and PC Licensing. It's products that will improve patient outcomes in the treatment of cardiovascular disease, cancer and benign tumours. Biocompatibles International was founded by Dennis Chapman in 1984 and is headquartered in Farnham, UK. | Chief Tech/Sci/R&D Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 6 |
---|---|
Arthro Kinetics Ltd.
Arthro Kinetics Ltd. Medical SpecialtiesHealth Technology Arthro Kinetics develops manufactures and markets advanced biological implants for joint regeneration and surgical instrument and access systems for endoscopic spine surgery. The Company aims to develop a portfolio of biological implants for insertion by endoscopic spine surgery techniques, thereby setting new standards of surgical care. The Company has developed and is marketing CaReS, its first biological cartilage repair product, and K.I.S.S., its comprehensive spinal surgical instruments system for endoscopic spinal access and surgical intervention. | Health Technology |
Reverse Medical Corp.
Reverse Medical Corp. Electronic Equipment/InstrumentsElectronic Technology Reverse Medical Corp. develops medical devices. The company was founded by Jeffrey Valko and Michael R. Henson in 2007 and is headquartered in Irvine, CA. | Electronic Technology |
Biocompatibles International Ltd.
Biocompatibles International Ltd. Miscellaneous Commercial ServicesCommercial Services Biocompatibles International Ltd. is a leading medical technology company in the field of drug device combination products with an Oncology products division and a Licensing division. In oncology, it has Bead products and BrachySciences and in Licensing, it has two components, CellMed and PC Licensing. It's products that will improve patient outcomes in the treatment of cardiovascular disease, cancer and benign tumours. Biocompatibles International was founded by Dennis Chapman in 1984 and is headquartered in Farnham, UK. | Commercial Services |
Earlybird Venture Capital GmbH & Co. KG
Earlybird Venture Capital GmbH & Co. KG Investment ManagersFinance Earlybird Venture Capital GmbH & Co. KG (Earlybird VC) is an independent venture capital firm founded by Hendrik Brandis, Roland Manger, Rolf Mathies, and Christian Nagel in 1997. It is a wholly-owned subsidiary of Earlybird VC Management GmbH & Co. KG. The firm is headquartered in Munich, Germany, with another German office in Berlin, and international office in Istanbul, Turkey. | Finance |
Thermocore Medical Ltd. | |
Cryotherapeutics SA
Cryotherapeutics SA Medical SpecialtiesHealth Technology Cryotherapeutics SA develops and markets a cryotherapy system, with focus on highlighting the safety and efficacy of cryoneergy in the cardiovascular system. The firm specializes in the design of a proprietary system to be used in the treatment of coronary artery diseases that cause heart attacks. Its focus areas encompass technology research, system development, and early-stage product commercialization. The company was founded by Randell L. Werneth, John Yianni and Maurice Buchbinder on September 8, 2009 and is headquartered in Cologne, Germany. | Health Technology |
- Stock Market
- Insiders
- John Yianni